WIRB-Copernicus IRB Fall Training - October 7, 2021
The goal is to provide education for physicians who participate in the the regulatory and ethical review of clinical research as members of a WCG IRB, on new regulatory requirements for the medical oversight of research, best practices for assessing medical risks in research studies, and the important considerations in the development of new medicines and clinical trials including diversity initiatives and the involvement of patient advocacy organizations.
The target audience for this activity is physicians who participate in the medical, ethical and regulatory review of research protocols and proposals as a member of WCG IRB.
Physicians will be better able to:
- provide clear assessments of the potential medical risks and potential benefits of clinical research protocols,
- assist in the determination of whether studies meet the criteria for approval to be conducted.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and WCG. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.00 Participation